Jacobs Engineering Group Inc.
(NYSE:JEC) announced today that the
Vaccine Bulk Manufacturing Facility (VBF) Program of Projects in Durham, N.C. was selected as the overall winner of the 2012 Facility of the Year Awards (FOYA) program.
Jacobs provided engineering, procurement, construction management and commissioning/validation services, as well as full modular design and fabrication for the manufacturing facility.
In making the announcement, Jacobs Group Vice President Bob Pragada stated, “For the VBF Program of Projects, the entire team, including 46 subcontractors and 50 suppliers, integrated seamlessly. It is an honor to support Merck in meeting their project needs, and to contribute to a facility that helps to improve the health and welfare of so many people.”
program recognizes pharmaceutical manufacturing projects that use new and innovative technologies to enhance project delivery and reduce production costs of high quality medicines. Now in its seventh year, the awards program effectively spotlights the accomplishments, shared commitment, and dedication of individuals in companies worldwide to innovate and advance pharmaceutical manufacturing technology for the benefit of all global consumers. This marks the second time in three years that Jacobs has worked on the winning project.
Jacobs is one of the world’s largest and most diverse providers of technical, professional, and construction services.
Statements made in this release that are not based on historical fact are forward-looking statements. We base these forward-looking statements on management’s current estimates and expectations as well as currently available competitive, financial and economic data. Forward-looking statements, however, are inherently uncertain. There are a variety of factors that could cause business results to differ materially from our forward-looking statements. For a description of some of the factors which may occur that could cause actual results to differ from our forward-looking statements please refer to our 2011 Form 10-K, and in particular the discussions contained under Items 1 - Business, 1A - Risk Factors, 3 - Legal Proceedings, and 7 - Management’s Discussion and Analysis of Financial Condition and Results of Operations. We do not undertake to update any forward-looking statements made herein.